Results

Total Results: 1,529 records

Showing results for "pre-launch".

  1. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2248-543/LHS+Case+Study_b6123d0d4a7f4dae8426d2e0801c9320-310723-2248-544.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  2. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2231-527/LHS+Case+Study_67094ce23e8b4dbcaafe16b4662a684e-310723-2231-528.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  3. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2237-533/LHS+Case+Study_e88c9f114ea648fba29b25b6c0d79ee8-310723-2237-534.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  4. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2243-539/LHS+Case+Study_7632f8ab625145bab5fcc413ada38987-310723-2243-540.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  5. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2242-537/LHS+Case+Study_0baad6f2feef4485b4e016e3e8766a50-310723-2242-538.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  6. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2245-541/LHS+Case+Study_3d0161879ea04f81b42e01f2282b2609-310723-2245-542.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  7. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2233-529/LHS+Case+Study_b03e9e6eef564667bb54fbdcce69f743-310723-2233-530.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  8. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2240-535/LHS+Case+Study_6fa4d480a6b148fe89ee618c0861cf83-310723-2240-536.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  9. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2219-515/LHS+Case+Study_e6e5c72878c1421c946df621f16d8c53-310723-2219-516.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  10. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2221-517/LHS+Case+Study_6cd79bbf53f24c9fbc39ecb6d41c1a65-310723-2221-518.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  11. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2223-519/LHS+Case+Study_e1562001159649108daa4f6034e1b6e5-310723-2223-520.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  12. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2225-521/LHS+Case+Study_0103474b93c94ca0bdbcd63cbb560ccb-310723-2225-522.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  13. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2228-523/LHS+Case+Study_2f4b1808cacf4724bd1a876539d8d215-310723-2228-524.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  14. cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2229-525/LHS+Case+Study_b27aaa0e6dd64a16a6dd5d5a24e100ab-310723-2229-526.pdf?contentType=application/pdf
    August 31, 2021 - LHS Case Study University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota ( )Team recognized the importance of MHealth Fairview hypercoagulability in COVID-19 and wanted to provide evidence-based support for deci…
  15. preventiveservices.ahrq.gov/sites/default/files/2024-04/finkelstein-report.pdf
    January 01, 2024 - Final Progress Report: Pediatric Quality Improvement Methods, Research, and Evaluation Conference 1. TITLE PAGE Pediatric Quality Improvement Methods, Research, and Evaluation Conference Jonathan Finkelstein, MD, MPH, Principal Investigator Team Members: Denise Dougherty, PhD Alex Kemper, MD, MPH, MS Lawrence K…
  16. psnet.ahrq.gov/web-mm/do-me-favor
    September 12, 2016 - Do Me a Favor Citation Text: Williamson A. Do Me a Favor. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2004. Copy Citation Format: Google Scholar BibTeX EndNote X3 XML EndNote 7 XML Endnote tagged PubMedId RIS …
  17. www.talkingquality.ahrq.gov/sites/default/files/publications/files/simulation-brief.pdf
    February 01, 2015 - Health Care Simulation to Advance Safety: AHRQ Issue Brief Foreword Simulation has long been recognized for the integral role it plays in high- risk industries. Our aerospace, transportation, and power-generation industries have become steadily safer over the years with the aid of simulation. As the Ebola virus di…
  18. www.cpsi.ahrq.gov/sites/default/files/publications/files/simulation-brief.pdf
    February 01, 2015 - Health Care Simulation to Advance Safety: AHRQ Issue Brief Foreword Simulation has long been recognized for the integral role it plays in high- risk industries. Our aerospace, transportation, and power-generation industries have become steadily safer over the years with the aid of simulation. As the Ebola virus di…
  19. www.qualitymeasures.ahrq.gov/sites/default/files/publications/files/simulation-brief.pdf
    February 01, 2015 - Health Care Simulation to Advance Safety: AHRQ Issue Brief Foreword Simulation has long been recognized for the integral role it plays in high- risk industries. Our aerospace, transportation, and power-generation industries have become steadily safer over the years with the aid of simulation. As the Ebola virus di…
  20. www.healthcare411.ahrq.gov/sites/default/files/publications/files/simulation-brief.pdf
    February 01, 2015 - Health Care Simulation to Advance Safety: AHRQ Issue Brief Foreword Simulation has long been recognized for the integral role it plays in high- risk industries. Our aerospace, transportation, and power-generation industries have become steadily safer over the years with the aid of simulation. As the Ebola virus di…